Need all Congresses? Press Enter for expanded federal results.

SB 594

Maryland Senate bill in Session 2026.

Status: enacted. Latest action: May 15, 2026.

Cannabis - Advertising - Alterations.

Bill ID MD-2026-SB-594
Session 2026
Status enacted
Committee Finance; Economic Matters
Senate enacted 2026-05-15
Drug / Cannabis Policy
Summary

Altering the ownership and control percentage requirement for a social equity applicant for a cannabis license; prohibiting cannabis advertising from directly targeting individuals under the age of 21 years; authorizing a standard dispensary to place exterior signage for a certain limited purposes; requiring the Maryland Cannabis Administration to accept certain advertising audience composition data and develop a process for accepting a certain attestation from a certain person regarding audience composition; etc.

Sponsor
Senator Beidle
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-02-05 Introduced Bill introduced
2026-05-15 Status enacted
2026-05-15 Latest Action Approved by the Governor - Chapter 416
More Bills From This Sponsor
SB 803
Alcoholic Beverages - Class 3 Wineries and Class 4 Limited Wineries - Alterations
enrolled • Senate
SB 804
Labor and Employment - Occupational Safety and Health - Revisions to Heat Stress Standards
introduced • Senate
SB 557
Gaming - Definition of "Own" - Alterations
passed_upper • Senate
SB 90
Workers' Compensation - Occupational Disease Presumptions - Hypertension
passed_upper • Senate
SB 374
Transportation - Rental Cars - Excise Tax Exemption
introduced • Senate
SB 413
State Board of Morticians and Funeral Directors - Board Operations and Regulation of Crematories and Reduction Facilities
enacted • Senate
More Bills In This Topic
HB 108
Division of Correction - Volunteer Services Program
enacted • House of Delegates
HB 1162
Correctional Services – Medication–Assisted Treatment Funding
introduced • House of Delegates
HB 1249
Certified Recovery Residences - Refusing Services to Individuals Receiving Medication-Assisted Treatment - Prohibition
enrolled • House of Delegates
HB 1285
Health - Opioid Overdose Reversal Drugs - Possession, Storage, and Administration Past Expiration Date
introduced • House of Delegates
HB 133
Income Tax and Sales and Use Tax - Rate Reductions and Alterations
introduced • House of Delegates
HB 1477
Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act)
introduced • House of Delegates
Related Topics
Healthcare
8 shared bills
Business / Commerce
5 shared bills
Tax / Budget / Appropriations
5 shared bills
Agriculture
3 shared bills
Labor / Employment
3 shared bills
Same Topic Bills From Other States
H.660
An act relating to fiscal year 2027 Opioid Abatement Special Fund appropriations
Vermont • 2026 • passed_lower
HB 5515
AN ACT CONCERNING THE DEPARTMENT OF MENTAL HEALTH AND ADDICTION SERVICES' RECOMMENDATIONS REGARDING ACCESS TO OPIOID OVERDOSE REVERSAL MEDICATION AND VARIOUS REVISIONS TO MENTAL HEALTH AND ADDICTION STATUTES.
Connecticut • 2026 • enacted
HB 2768
INDUSTRIAL HEMP-DERIVED CONSUMABLE PRODUCTS
Missouri • 2026-R • in_committee
HB 8265
AN ACT RELATING TO FOOD AND DRUGS -- THE RHODE ISLAND CANNABIS ACT
Rhode Island • 2026 • introduced
HB 1268
AN ACT to amend Tennessee Code Annotated, Title 8; Title 10; Title 16; Title 37; Title 38; Title 39; Title 40; Title 41 and Title 55, relative to criminal justice.
Tennessee • 114 • enacted
HB 195
An Act changing the term 'physician assistant' to 'physician associate'; relating to physician associates; relating to collaborative practice agreements for pharmacists; relating to the prescription of opioid overdose drugs; relating to the prescription and administration of drugs and devices by pharmacists; relating to reciprocity for pharmacists; amending the definition of 'practitioner'; and providing for an effective date.
Alaska • 34 • enacted